PTC Therapeutics, Inc. (PTCT): Net Income
$682.64M
Year ended 2025-12-31
-$38.38M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $682.64M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$363.30M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$626.60M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$559.02M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$523.90M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$438.16M | n/m | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | -$251.58M | n/m | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | -$128.08M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$79.00M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$142.11M | n/m | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | -$170.45M | n/m | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | -$93.75M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$51.57M | n/m | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | -$26.23M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $30.90M | n/a | 2014-03-06, From 2011-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $682.64M | n/m |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $99.72M | +106.6% |
| Alkermes plc. (ALKS) | 2025-12-31 | $241.66M | -34.2% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$713.41M | n/m |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $770.95M | -10.2% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $210.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $190.30M | -11.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $391.00M | +72.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $72.06M | n/m |
Compare PTCT, PAHC, ALKS, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗